Literature DB >> 9550577

Serum paraoxonase and platelet-activating factor acetylhydrolase in chronic renal failure.

O Hasselwander1, D McMaster, D G Fogarty, A P Maxwell, D P Nicholls, I S Young.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9550577

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

Review 1.  Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease.

Authors:  Kazuhiko Kotani; Satoshi Kimura; Alejandro Gugliucci
Journal:  J Physiol Biochem       Date:  2011-04-12       Impact factor: 4.158

2.  Assessment of the relationship between serum paraoxonase activity and epicardial adipose tissue in hemodialysis patients.

Authors:  Emad Abdallah; Samya El-Shishtawy; Nevine Sherif; Ahmed Ali; Omnia El-Bendary
Journal:  Int Urol Nephrol       Date:  2016-11-23       Impact factor: 2.370

3.  Paraoxonase: Its antiatherogenic role in chronic renal failure.

Authors:  M Prakash; N M Phani; R Kavya; M Supriya
Journal:  Indian J Nephrol       Date:  2010-01

4.  Serum Paraoxonase Levels are Correlated with Impaired Aortic Functions in Patients with Chronic Kidney Disease.

Authors:  Tolga H Efe; Ahmet G Ertem; Alpaslan Altunoglu; Cemal Koseoglu; Ali Erayman; Murat Bilgin; Özge Kurmuş; Turgay Aslan; Mehmet Bilge
Journal:  Acta Cardiol Sin       Date:  2016-01       Impact factor: 2.672

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.